Tissue Diagnostics Industry Size

Tissue Diagnostics Market worth $8.4 billion by 2028

The report "Tissue Diagnostics Market by Product (Consumables (Antibodies, Reagents, Tissue, Probes), Instrument (Processing System, Scanner)), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Global Forecast to 2028", is projected to reach USD 8.4 billion by 2028 from USD 5.6 billion in 2023, at a CAGR of 8.4% during the forecast period. The tissue diagnostics market is driven by the growing healthcare expenditure, and growing demand for digital pathology are the major factors driving the growth of the market. Growth in emerging countries and development of condition specific biomarkers and tests are anticipated to offer lucrative growth opportunities for the tissue diagnostics market.

Browse 172 market data Tables and 57 Figures spread through 240 Pages and in-depth TOC on "Tissue Diagnostics Market by Product (Consumables (Antibodies, Reagents, Tissue, Probes), Instrument (Processing System, Scanner)), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html

In 2022, the Antibodies in the consumablessegmentisholds  the largest share of the tissue diagnostics market, by product segment.

The global tissue diagnostics market is divided into consumables (Antibodies, Kits, Reagents, and Probes) and Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, and Other Instruments [automated cover slippers, microtomes, embedding systems, paraffin dispensers, and slide labelers]). This dominance is anticipated to persist, solidifying antibodies as a leading driver in the tissue diagnostics market, part of a segment that encompasses kits, reagents, and probes. The increased usage of consumables like kits and reagents contributes significantly to the rising demand for these products in cancer diagnosis. These kits play a dual role, aiding not only in diagnosing cancers but also in facilitating research. Hence, the increasing utilization of antibodies and kits in diagnostic and research capacities significantly fuels the expansion of the reagents and kits product segment.

The hospitals segment accounted for the largest share of the tissue market, by end user, in 2022.

The hospitals segment is expected expected to dominate the global tissue diagnostics market in 2022. The substantial segment share stems from several factors such as surge in hospital visits by patients, an uptick in in-house diagnostic procedures within hospital settings, heightened awareness surrounding early diagnosis, and the presence of reimbursements in developed markets for clinical tests conducted within hospitals.

North America is the largest regional market for tissue diangostic market.

The global tissue diagnostics market has been segmented into—North America, Europe, the Asia Pacific, and  Rest of the World. In 2022, North America dominated the global tissue diagnostics market in 2022. The Increasing healthcare expenditure, and high-quality infrastructure for hospitals and clinical laboratories are the key factors driving market growth in the US.

Don’t miss out on business opportunities in Tissue Diagnostics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Tissue Diagnostics Market Size,  Share & Growth Report
Report Code
MD 2349
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Tissue Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status

Digital Virtual Assistant - MarketsandMarkets